部分胃切除术后患者的埃沃洛库马布诱导过敏反应:一个病例报告
Xuxi Hong1, Xuehui Jiang2, Xiaohui Xu3
1Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Medicine
|December 23, 2025
概括
之前经过胃切除术的患者可能会增加对PCSK9抑制剂埃沃洛库马布 (evolocumab) 的过敏风险. 服用后仔细监测对于管理潜在的过敏反应至关重要.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 作为PCSK9抑制剂的Evolocumab用于降低脂质.
- 它在胃肠道解剖变化的患者中的安全性,如胃切除术后,尚未明确.
- 过敏反应可能与这些患者的免疫变化有关.
研究的目的:
- 评估具有部分胃切除病史的患者对evolocumab的安全性和过敏风险.
- 为了突出潜在的免疫失调影响药物耐受性后手术.
主要方法:
- 一个55岁男性的病例研究,患有PCI后的CAD,接受了evolocumab.
- 监测不良事件,特别是过敏反应.
- 用皮质类固醇和抗胰岛素治疗过敏性皮疹.
主要成果:
- 患者在evolocumab服药后24小时内可能出现过敏性皮疹和.
- 药物停止和过敏治疗后48小时内症状消失.
- 在一周的随访期内,观察到完全康复,没有后续症状.
结论:
- 部分胃切除可能会增加对evolocumab过敏反应的风险.
- 手术后免疫微环境的变化可能会导致过敏风险增加.
- 治疗前对外科病史的评估和治疗后的警监测是必不可少的.
相关概念视频
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...

